LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced that Company President and CEO Steven A. Kriegsman received the Lou Gehrig Memorial Award from the Muscular Dystrophy Association. The award was presented in recognition of CytRx’s dedication to finding a cure for amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease) at the Phil Villapiano Field of Hope Gala, A Celebrity Event to Benefit ALS Research, on October 28, 2006.
